Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating anxiety neurosis

A composition and technology for anxiety disorders, applied in the direction of drug combination, drug delivery, application, etc., can solve problems such as blurred vision, confusion, and fatigue

Inactive Publication Date: 2009-06-10
戚郁芬 +1
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, side effects such as insomnia, allergies, muscle pain, weakness, nausea, movement disorders, blurred vision, tiredness, confusion, delusions, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating anxiety neurosis
  • Medicine composition for treating anxiety neurosis
  • Medicine composition for treating anxiety neurosis

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0078] The pharmaceutical composition of the present invention, wherein the preparation method of the raw material containing jujube cyclic adenosine monophosphate comprises the following steps:

[0079] (a) extracting jujube to obtain a first extract; and

[0080] (b) purifying the first extract to obtain a second extract, and the concentration of adenosine monophosphate in the second extract is higher than the concentration of adenosine monophosphate in the first extract.

[0081] Scheme seventeen:

[0082] In the above-mentioned preparation method, the step (b) is to use a macroporous resin containing aldehyde groups to adsorb and separate the jujube cyclic adenosine monophosphate in the first extract.

[0083] Scheme eighteen:

[0084] In the aforementioned preparation method, the step (b) is to select an aldehyde-containing macroporous resin OU-2 to adsorb and separate the jujube cyclic adenosine monophosphate in the first extract.

[0085] Plan nineteen:

[0086] In ...

Embodiment 1

[0133] see figure 1 , is a schematic flow chart of the method for preparing the medicine of Example 1 of the present invention. exist figure 1 In the process, 20kg of ginseng was crushed first, then heated and extracted with 70% ethanol solution, separated and purified by upper column chromatography, and dried to obtain 0.8kg of ginseng extract containing 120g ginsenosides (Rg1+Rb1); then, 10kg The broken licorice was soaked at room temperature for 12 hours, extracted with water and alcohol precipitation, concentrated and dried to obtain 2 kg of licorice extract containing 200 g of glycyrrhizic acid; after that, 150 g of ginseng extract obtained by the above method and 200 g of licorice extract were pulverized and mixed uniformly Afterwards, obtain 350g (containing 22.5g ginsenoside Rg1+Rb1 and 20g glycyrrhizic acid) pharmaceutical composition of the present invention.

Embodiment 2

[0135] see figure 2 , is a schematic flow chart of the method for preparing the drug of Example 2 of the present invention. exist figure 2 3.96g of glycyrrhetinic acid with a purity of 96% and 200g of the ginseng extract obtained in Example 1 were pulverized and mixed uniformly to obtain 203.96g (containing 30g ginsenosides Rg1+Rb1 and 3.8g glycyrrhetinic acid). Invented pharmaceutical compositions.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition or health food for treating anxiety neurosis made from the raw materials containing ginsenoside (Rg1+Rb1), glycyrrhetic acid and chinese date cAMP, especially a pharmaceutical composition or health food for treating anxiety neurosis with definite functions, evident effects, low side effect and high safety for long term taking. The experiments verify that: comparing with mainstream medicines for treating anxiety neurosis in current technology, such as Diazepam, the medicine in the invention achieves more remarkable anti-dysphoria effect.

Description

technical field [0001] The invention relates to a group of raw materials including ginsenoside (Rg1+Rb1), glycyrrhizic acid and jujube cAMP, which are used to prepare a pharmaceutical composition or health food for treating anxiety. In particular, it refers to a pharmaceutical composition or health food for treating anxiety with clear functional components, obvious curative effect, low side effects and high safety for long-term administration. Background technique [0002] Mental disorders, also known as mental illnesses, refer to abnormalities in perception, thinking, emotion, behavior, volition, intelligence, and other psychomotor aspects caused by brain dysfunction under the influence of biological, social, and psychological factors. With the development of society, people pay more and more attention to mental disorders. Among the 10 diseases that cause the heaviest burden on society, mental diseases account for 4 of them. Psychiatry is gradually receiving the attention ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/484A61K36/725A61K9/00A61K9/08A61K9/10A61K9/14A61K9/16A61K9/20A61K9/48A61P25/22A23L1/29
Inventor 张作光
Owner 戚郁芬
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com